Effects of neuroprotector cortexin on the dynamics of neuroendocrine system parameters in patients with organic emotionally labile (asthenic) disorders
Comparison in people · 2013
- What was studied
- Patients with organic emotionally labile/asthenic disorders
- Main finding
- Reports endocrine changes alongside clinical improvement when Cortexin was added to standard treatment.
Reported findings and study design
Population or model Patients with organic emotionally labile/asthenic disorders
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Neuroendocrine measures | Cortisol, DHEA-sulphate and thyroid-hormone changes reported during adjunctive care |
No numerical effect estimate or adequately documented allocation is available in the abstract. Hormone-marker changes are not a general recovery benefit.
Source for these results ↗ · Reviewed 2026-11-05
Study limitations and source details
Study limitations
- Abstract-level record does not adequately describe allocation, blinding or sample size.
- Hormone changes do not validate general stress resilience or healthy-person enhancement.
Source details
Indexed abstract and citation checked via Europe PMC / PubMed; full methods and risk of bias not appraised.
Sources checked
Citation
Levchuk LA, Ivanova SA, Semke VY. Effects of neuroprotector cortexin on the dynamics of neuroendocrine system parameters in patients with organic emotionally labile (asthenic) disorders Bull Exp Biol Med 155(1):75-77. PMID 23667876
Study source ↗ · DOI 10.1007/s10517-013-2083-7 · Bibliography entry · Link to this summary